SONA Asset Management (US)’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

SONA Asset Management (US)’s Portfolio ROIVW Stock Details ROIVW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-40,821	Closed	-$193K	–	341
2022 Q1	$193K	Sell	40,821 -34,179	-46%	-$43.4K	0.11%	195
2021 Q4	$152K	Buy	+75,000	New	+$114K	0.08%	145

Other funds holding ROIVW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SONA Asset Management (US)'s ROIVW Position: Q2 2022 in Review

SONA Asset Management (US) sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q2 2022, closing a stake of 40,821 shares — an estimated $193K sold.

SONA Asset Management (US) first reported a position in ROIVW in Q4 2021 and held it in 2 quarters. The position peaked at $193K in Q1 2022. 31 funds tracked by Wall St. Rank hold ROIVW as of Q2 2022.

SONA Asset Management (US) reported no remaining Roivant Sciences Ltd. Warrant position as of Q2 2022 after selling out during the quarter.
SONA Asset Management (US) sold 40,821 Roivant Sciences Ltd. Warrant shares in Q2 2022, an estimated $193K.
SONA Asset Management (US) first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 2 quarters.
SONA Asset Management (US)'s Roivant Sciences Ltd. Warrant position peaked at $193K in Q1 2022.
31 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q2 2022.

Based on SONA Asset Management (US)'s 13F filing for Q2 2022, filed 15 Aug 2022.